These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6732781)

  • 41. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.
    Han YN; Komiya M; Iwanaga S; Suzuki T
    J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary structure of PDC-109, a major protein constituent of bovine seminal plasma.
    Esch FS; Ling NC; Böhlen P; Ying SY; Guillemin R
    Biochem Biophys Res Commun; 1983 Jun; 113(3):861-7. PubMed ID: 6870895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification and characterization of an acid protease and vasopeptide kinins from Murphy-Sturm lymphosarcoma.
    Bedi GS; Balwierczak J; Back N
    Adv Exp Med Biol; 1983; 156 (Pt B)():705-26. PubMed ID: 6344582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The crystallizable human myeloma protein Dob has a hinge-region deletion.
    Steiner LA; Lopes AD
    Biochemistry; 1979 Sep; 18(19):4054-67. PubMed ID: 114208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrophobic properties of porcine fibronectin and its functional domains.
    Hayashi-Nagai A; Kitagaki-Ogawa H; Matsumoto I; Hayashi M; Seno N
    J Biochem; 1991 Jan; 109(1):83-8. PubMed ID: 2016277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimers.
    Homandberg GA; Amrani DL; Evans DB; Kane CM; Ankel E; Mosesson MW
    Arch Biochem Biophys; 1985 May; 238(2):652-63. PubMed ID: 3994396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complete amino acid sequence of a 50,000-dalton fragment of human ceruloplasmin.
    Dwulet FE; Putnam FW
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):790-4. PubMed ID: 6940148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human transferrin C: the sequence and cystine bridges of the N-terminal region.
    Brune JE; Martin SR; Boyd BS; Palmour RM; Sutton HE
    Tex Rep Biol Med; 1978; 36():47-61. PubMed ID: 725796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The phosphate content of human fibronectin.
    Ledger PW; Tanzer ML
    J Biol Chem; 1982 Apr; 257(7):3890-5. PubMed ID: 7061516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
    McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
    J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of disulfide array and subunit structure of taste-modifying protein, miraculin.
    Igeta H; Tamura Y; Nakaya K; Nakamura Y; Kurihara Y
    Biochim Biophys Acta; 1991 Sep; 1079(3):303-7. PubMed ID: 1911854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The isolation and characterization of bovine C4a, an activation fragment of the fourth component of complement.
    Booth NA; Campbell RD; Smith MA; Fothergill JE
    Biochem J; 1979 Dec; 183(3):573-8. PubMed ID: 540031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rule of antibody structure. the primary structure of a monoclonal IgG1 immunoglobulin (myeloma protein Nie), I: Purification and characterization of the protein, the L- and H-chains, the cyanogenbromide cleavage products, and the disulfide bridges (author's transl)].
    Dreker L; Schwarz J; Reichel W; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1976 Nov; 357(11):1515-40. PubMed ID: 1002129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments.
    Takagi T; Doolittle RF
    Biochemistry; 1975 Mar; 14(5):940-6. PubMed ID: 123758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the presence of a free N-terminal fibronectin 30-kDa domain in human plasma by quantitative determination with an indirect immunosorbent assay.
    Skrha J; Richter H; Hörmann H
    Anal Biochem; 1988 Sep; 173(2):228-34. PubMed ID: 3056103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human plasma fibronectin possesses second binding site(s) to Staphylococcus aureus on its C-terminal region.
    Sakata N; Jakab E; Wadström T
    J Biochem; 1994 May; 115(5):843-8. PubMed ID: 7961595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rule of antibody structure. Primary structure of a human monoclonal IgA-immunoglobulin (myeloma protein Tro). VII. Purification and characterization of the disulfide bridges].
    Yang C; Kratzin H; Götz H; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1919-40. PubMed ID: 393607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Smith MA; Gerrie LM; Dunbar B; Fothergill JE
    Biochem J; 1982 Nov; 207(2):253-60. PubMed ID: 6760852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic peptides of the amino-terminus of fibronectin inhibit endothelial cell growth.
    Homandberg GA; Dunn BM; Grant DM; Schumacher B; Bartley DM; Eisenstein R
    Cell Biol Int Rep; 1989 Oct; 13(10):891-900. PubMed ID: 2805079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.